Cargando…

Unusual deterioration in a patient with multiple sclerosis on natalizumab therapy

Detalles Bibliográficos
Autores principales:	Gattringer, Thomas, Enzinger, Christian, Khalil, Michael, Schwingenschuh, Petra, Pichler, Alexander, Moser, Alexander, Graninger, Winfried, Ernst, Christina, Haybaeck, Johannes, Fazekas, Franz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2014
Materias:	Clinical/Scientific Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202682/ https://www.ncbi.nlm.nih.gov/pubmed/25340053 http://dx.doi.org/10.1212/NXI.0000000000000001

Ejemplares similares

Morphological MRI phenotypes of multiple sclerosis differ in resting-state brain function
por: Pinter, Daniela, et al.
Publicado: (2019)

Natalizumab Promotes Activation of Peripheral Monocytes in Patients With Multiple Sclerosis
por: Frisch, Esther S., et al.
Publicado: (2023)

The effect of disease modifying therapies on CD62L expression in multiple sclerosis
por: Voortman, Margarete Maria, et al.
Publicado: (2018)

Incomplete Susac syndrome exacerbated after natalizumab
por: Zhovtis Ryerson, Lana, et al.
Publicado: (2015)

Incidence of Developmental Venous Anomalies in Patients With Multiple Sclerosis: A 3 Tesla MRI Study
por: Magyar, Marton, et al.
Publicado: (2022)

Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS
por: Hodecker, Sibylle C., et al.
Publicado: (2017)

Natalizumab may control immune checkpoint inhibitor–induced limbic encephalitis
por: Hottinger, Andreas F., et al.
Publicado: (2018)

VZV-associated acute retinal necrosis in a patient with MS treated with natalizumab
por: Pawlitzki, Marc, et al.
Publicado: (2018)

Higher Education Moderates the Effect of T2 Lesion Load and Third Ventricle Width on Cognition in Multiple Sclerosis
por: Pinter, Daniela, et al.
Publicado: (2014)

Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis
por: Pinter, Daniela, et al.
Publicado: (2015)

Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc
por: Bsteh, Gabriel, et al.
Publicado: (2017)

Natalizumab granule cell neuronopathy: FDG-PET in diagnosis and immune reconstitution with G-CSF
por: Kamourieh, Salwa, et al.
Publicado: (2017)

Rescue of severe brain and cervical cord IRIS by restarting natalizumab in a pregnant MS patient
por: Massey, Thomas H., et al.
Publicado: (2017)

Reproducibility of Resting State Connectivity in Patients with Stable Multiple Sclerosis
por: Pinter, Daniela, et al.
Publicado: (2016)

Progressive multifocal leukoencephalopathy and granule cell neuronopathy with novel mutation flanking VP1 C-terminus in natalizumab-extended interval dosing
por: Rempe, Torge, et al.
Publicado: (2020)

Mucosal biopsy shows immunologic changes of the colon in patients with early MS
por: Moser, Adrian Mathias, et al.
Publicado: (2017)

Interferons and Natalizumab for Multiple Sclerosis
por: Clar, Christine, et al.
Publicado: (2008)

Natalizumab in the treatment of multiple sclerosis
por: Brown, Brandon A
Publicado: (2009)

The use of natalizumab for multiple sclerosis
por: Brandstadter, Rachel, et al.
Publicado: (2017)

Natalizumab Rebound in Multiple Sclerosis
por: Lee, Joshua D., et al.
Publicado: (2021)

An exploratory intervention study suggests clinical benefits of training in chronic stroke to be paralleled by changes in brain activity using repeated fMRI
por: Landsmann, Barbara, et al.
Publicado: (2016)

Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis
por: Callegari, Ilaria, et al.
Publicado: (2023)

Natalizumab for the treatment of relapsing multiple sclerosis
por: Rudick, Richard A, et al.
Publicado: (2008)

Levodopa-responsive Holmes’ Tremor Caused by a Single Inflammatory Demyelinating Lesion
por: Katschnig-Winter, Petra, et al.
Publicado: (2015)

Pregnancy Outcomes in Patients With Multiple Sclerosis Exposed to Natalizumab—A Retrospective Analysis From the Austrian Multiple Sclerosis Treatment Registry
por: Guger, Michael, et al.
Publicado: (2020)

Brain Activity Changes in Cognitive Networks in Relapsing-Remitting Multiple Sclerosis – Insights from a Longitudinal fMRI Study
por: Loitfelder, Marisa, et al.
Publicado: (2014)

Disseminated Histoplasmosis in a Patient With Multiple Sclerosis Treated With Fingolimod
por: Abrahamowicz, Aleksandra A., et al.
Publicado: (2021)

Natalizumab in Multiple Sclerosis: Long-Term Management
por: Clerico, Marinella, et al.
Publicado: (2017)

Glioblastoma in natalizumab‐treated multiple sclerosis patients
por: Sierra Morales, Fabian, et al.
Publicado: (2017)

Multimodal assessment of white matter tracts in amyotrophic lateral sclerosis
por: Borsodi, Florian, et al.
Publicado: (2017)

Ventilation time and prognosis after stroke thrombectomy: the shorter, the better!
por: Fandler‐Höfler, S., et al.
Publicado: (2020)

Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)
por: Monschein, Tobias, et al.
Publicado: (2023)

Serum netrin-1 in relation to gadolinium-enhanced magnetic resonance imaging in early multiple sclerosis
por: Voortman, MM, et al.
Publicado: (2017)

Unusual neurologic presentation of aseptic abscesses syndrome
por: Nicolas, Philippe, et al.
Publicado: (2018)

Are morphologic features of recent small subcortical infarcts related to specific etiologic aspects?
por: Eppinger, Sebastian, et al.
Publicado: (2019)

Multiple sclerosis–like lesions and type I interferon signature in a patient with RVCL
por: Schuh, Elisabeth, et al.
Publicado: (2014)

An unusual case of miliary PML-IRIS in an HIV+ patient
por: Cuendet, David, et al.
Publicado: (2017)

Measuring Gray Matter and White Matter Damage in MS: Why This is Not Enough
por: Enzinger, Christian, et al.
Publicado: (2015)

Correction: Real-world use of natalizumab in Austria: data from the Austrian Multiple Sclerosis Treatment Registry (AMSTR)
por: Monschein, Tobias, et al.
Publicado: (2023)

Risk Acceptance in Multiple Sclerosis Patients on Natalizumab Treatment
por: Tur, Carmen, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ec8f71thg08s1fhcq1jfuspmpm